Here are relevant reports on : rna-synthesis-market
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019
The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.
- Published: February 2015
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
High Potency APIs Market / HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) & Region - Global Forecast to 2027
The global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Dimethyl Carbonate Market by Application (Polycarbonate Synthesis, Battery Electrolyte, Solvents, Reagents), End-use Industry (Plastics, Paints & Coatings, Pharmaceutical), Grade (Industry, Pharmaceutical, Battery), and Region - Global Forecast to 2030
The global dimethyl carbonate market is projected to grow from USD 1.56 billion in 2025 to USD 2.63 billion by 2030, at a CAGR of 11.1% during the forecast period. Leading players in this market include UBE Corporation (Japan), LOTTE Chemical Corporation (South Korea), Shinghwa Advanced Material Group Co.,Ltd. (China), Sankyo Chemical Corporation (Japan), Shandong AIVK Chemical Co., Ltd. (China), Hi-tech Spring (China), Shandong depu chemical industry science&technology co.,ltd (China), Enam Organics India Ltd (India), Shandong Hualu Hengsheng Group Co.(China), Zhengzhou Meiya Chemical Products Co. (China), Shandong Daze Chemical Group (China), Shandong Longze Chemical Co.,Ltd (China), Shandong Wanling Chemical Co. LTD (China), Haihang Industry (China), Shandong Chemical Co., Ltd. (China), and Henan GP Chemicals Co. (China).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Europe Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Europe Oligonucleotide Synthesis market, valued at USD 2.68 billion in 2024, stood at USD 3.17 billion in 2025 and is projected to advance at a resilient CAGR of 18.7% from 2025 to 2030, culminating in a forecasted valuation of USD 7.49 billion by the end of the period. The market is growing due to strong demand from therapeutics, diagnostics, and research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Acetonitrile Market by Type (Derivative, Solvent), Application (Organic Synthesis, Analytical Applications, Extraction), End-use Industry (Pharmaceutical, Analytical industry, Agrochemical), Region - Global Forecast to 2028
The acetonitrile market is expected to grow from USD 439 million in 2023 to USD 595 million by 2028, at a CAGR of 6.2% during the forecast period. Prominent companies in the acetonitrile market include INEOS AG (Switzerland.), Asahi Kasei Corporation (Japan), Nova Molecular Technologies (US), PetroChina Co. Ltd. (China), Formosa Plastic Corporation (Taiwan), ShengHong Petrochemical Group Co. Ltd. (China), Avantor Performance Materials LLC (US), Imperial Chemical Corporation (Taiwan), Tedia Company Inc. (US), Avantor Performance Materials, LLC (US), Shanghai Secco Petrochemical Company Limited (China), Qingdao Shida Chemical Co., Ltd. (China), Nantong Acetic Acid Chemical Co., Ltd. (China), and others.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Asia Pacific Oligonucleotide Synthesis market, valued at USD 1.76 billion in 2024, stood at USD 2.08 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2025 to 2030, culminating in a forecasted valuation of USD 4.88 billion by the end of the period. This expansion is driven by increasing demand from therapeutics, diagnostics, and research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
